_id

69105e75ccc777a4e85d5920

Ticker

DXR

Name

Daxor Corporation

Exchange

NASDAQ

Address

109 Meco Lane, Oak Ridge, TN, United States, 37830

Country

USA

Sector

Healthcare

Industry

Medical Instruments & Supplies

Currency

USD

Website

https://www.daxor.com

Description

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

Last Close

12.33

Volume

667

Current Price

12.2501

Change

-0.6480129764801322

Last Updated

2025-11-29T12:28:51.466Z

Image

data:image/webp;base64,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

Ipo Date

1992-03-17T00:00:00.000Z

Market Cap

66293212

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

4.5

Target Price

22

Strong Buy

1

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-06-30

Revenue

18348

Cost Of Revenue

78202

Gross Profit

18348

Operating Expenses

287847

Operating Income

-269499

Interest Expense

12617

Pretax Income

-369701

Net Income

-369701

Eps

-0.07417084164919233

Dividends Per Share

-

Shares Outstanding

4984452

Income Tax Expense

-

EBITDA

-

Operating Margin

-1468.8194898626555

Total Other Income Expense Net

-100202

Cash

-

Short Term Investments

-

Receivables

1813

Inventories

-

Total Current Assets

-

Property Plant Equipment

-

Total Assets

35900241

Payables

9500

Short Term Debt

-

Long Term Debt

-

Total Liabilities

272427

Equity

35627814

Depreciation

276955

Change In Working Capital

-93745

Cash From Operations

467039

Capital Expenditures

4

Cash From Investing

773993

Cash From Financing

-467039

Net Change In Cash

-

PE

83.125

PB

1.7138305326619254

ROE

-1.0376752275623757

ROA

-1.029800886294886

FCF

467035

Fcf Percent

25.454272945280138

Piotroski FScore

2

Health Score

54

Deep Value Investing Score

5

Defensive Investing Score

5

Dividend Investing Score

3

Economic Moat Investing Score

6.8

Garp Investing Score

4

Growth Investing Score

3

Momentum Investing Score

6.5

Net Net Investing Score

3.5

Quality Investing Score

4.5

Value Investing Score

5.5

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

18348

Quarters > 0 > income Statement > cost Of Revenue

78202

Quarters > 0 > income Statement > gross Profit

18348

Quarters > 0 > income Statement > operating Expenses

287847

Quarters > 0 > income Statement > operating Income

-269499

Quarters > 0 > income Statement > interest Expense

12617

Quarters > 0 > income Statement > pretax Income

-369701

Quarters > 0 > income Statement > net Income

-369701

Quarters > 0 > income Statement > eps

-0.07417084164919233

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

4984452

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-

Quarters > 0 > income Statement > operating Margin

-1468.8194898626555

Quarters > 0 > income Statement > total Other Income Expense Net

-100202

Quarters > 0 > balance Sheet > cash

-

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

1813

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

-

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

35900241

Quarters > 0 > balance Sheet > payables

9500

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

272427

Quarters > 0 > balance Sheet > equity

35627814

Quarters > 0 > cash Flow > net Income

-369701

Quarters > 0 > cash Flow > depreciation

276955

Quarters > 0 > cash Flow > change In Working Capital

-93745

Quarters > 0 > cash Flow > cash From Operations

467039

Quarters > 0 > cash Flow > capital Expenditures

4

Quarters > 0 > cash Flow > cash From Investing

773993

Quarters > 0 > cash Flow > cash From Financing

-467039

Quarters > 0 > cash Flow > net Change In Cash

-

Quarters > 0 > ratios > PE

-0.07417084164919233

Quarters > 0 > ratios > PB

1.7138305326619254

Quarters > 0 > ratios > ROE

-1.0376752275623757

Quarters > 0 > ratios > ROA

-1.029800886294886

Quarters > 0 > ratios > FCF

467035

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

25.454272945280138

Quarters > 0 > health Score

54

Quarters > 1 > quarter

2024-12-31

Quarters > 1 > income Statement > revenue

695307

Quarters > 1 > income Statement > cost Of Revenue

74644

Quarters > 1 > income Statement > gross Profit

620663

Quarters > 1 > income Statement > operating Expenses

1225253

Quarters > 1 > income Statement > operating Income

2205321

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

2167151

Quarters > 1 > income Statement > net Income

2167151

Quarters > 1 > income Statement > eps

0.4392118085632026

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

4934182

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

3341280

Quarters > 1 > income Statement > operating Margin

317.1722706660511

Quarters > 1 > income Statement > total Other Income Expense Net

-38170

Quarters > 1 > balance Sheet > cash

-

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

9678

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

18568

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

36632597

Quarters > 1 > balance Sheet > payables

110330

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

840296

Quarters > 1 > balance Sheet > equity

35792301

Quarters > 1 > cash Flow > net Income

2167151

Quarters > 1 > cash Flow > depreciation

1135959

Quarters > 1 > cash Flow > change In Working Capital

40773

Quarters > 1 > cash Flow > cash From Operations

-502047

Quarters > 1 > cash Flow > capital Expenditures

3

Quarters > 1 > cash Flow > cash From Investing

1421722

Quarters > 1 > cash Flow > cash From Financing

-919675

Quarters > 1 > cash Flow > net Change In Cash

-

Quarters > 1 > ratios > PE

0.4392118085632026

Quarters > 1 > ratios > PB

1.6887492904745072

Quarters > 1 > ratios > ROE

6.054796532919188

Quarters > 1 > ratios > ROA

5.915908719220753

Quarters > 1 > ratios > FCF

-502050

Quarters > 1 > ratios > Piotroski FScore

2

Quarters > 1 > ratios > fcf Percent

-0.7220551497396114

Quarters > 1 > health Score

60

Quarters > 2 > quarter

2024-06-30

Quarters > 2 > income Statement > revenue

71756

Quarters > 2 > income Statement > cost Of Revenue

90239

Quarters > 2 > income Statement > gross Profit

71756

Quarters > 2 > income Statement > operating Expenses

369306

Quarters > 2 > income Statement > operating Income

-297550

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-3261634

Quarters > 2 > income Statement > net Income

-1630818

Quarters > 2 > income Statement > eps

-0.3376543838682989

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

4829844

Quarters > 2 > income Statement > income Tax Expense

-1630816

Quarters > 2 > income Statement > EBITDA

-1283062

Quarters > 2 > income Statement > operating Margin

-414.6691565862088

Quarters > 2 > income Statement > total Other Income Expense Net

-2964084

Quarters > 2 > balance Sheet > cash

-

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

13715

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

20064

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

34375505

Quarters > 2 > balance Sheet > payables

-

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

1720244

Quarters > 2 > balance Sheet > equity

32655261

Quarters > 2 > cash Flow > net Income

-1630817

Quarters > 2 > cash Flow > depreciation

300836

Quarters > 2 > cash Flow > change In Working Capital

-26680

Quarters > 2 > cash Flow > cash From Operations

-1412757

Quarters > 2 > cash Flow > capital Expenditures

3

Quarters > 2 > cash Flow > cash From Investing

1037546

Quarters > 2 > cash Flow > cash From Financing

893984

Quarters > 2 > cash Flow > net Change In Cash

518773

Quarters > 2 > ratios > PE

-0.3376543838682989

Quarters > 2 > ratios > PB

1.8118388943331365

Quarters > 2 > ratios > ROE

-4.99404368564073

Quarters > 2 > ratios > ROA

-4.7441281226268535

Quarters > 2 > ratios > FCF

-1412760

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-19.688388427448576

Quarters > 2 > health Score

35

Quarters > 3 > quarter

2024-03-31

Quarters > 3 > income Statement > revenue

35878

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

35878

Quarters > 3 > income Statement > operating Expenses

184653

Quarters > 3 > income Statement > operating Income

-148775

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-815409

Quarters > 3 > income Statement > net Income

-815409

Quarters > 3 > income Statement > eps

-0.1684710194408948

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

4840055

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

1643

Quarters > 3 > income Statement > operating Margin

-414.6691565862088

Quarters > 3 > income Statement > total Other Income Expense Net

-666634

Quarters > 3 > balance Sheet > cash

-

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

13715

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

20064

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

34375505

Quarters > 3 > balance Sheet > payables

-

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

1720244

Quarters > 3 > balance Sheet > equity

32655261

Quarters > 3 > cash Flow > net Income

-815409

Quarters > 3 > cash Flow > depreciation

150418

Quarters > 3 > cash Flow > change In Working Capital

-13340

Quarters > 3 > cash Flow > cash From Operations

-446992

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

446992

Quarters > 3 > cash Flow > net Change In Cash

-

Quarters > 3 > ratios > PE

-0.1684710194408948

Quarters > 3 > ratios > PB

1.8156693880198969

Quarters > 3 > ratios > ROE

-2.497021842820365

Quarters > 3 > ratios > ROA

-2.3720640613134267

Quarters > 3 > ratios > FCF

-446992

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-12.458665477451364

Quarters > 3 > health Score

35

Valuation > metrics > PE

83.125

Valuation > metrics > PB

1.7138305326619254

Valuation > final Score

50

Valuation > verdict

116.3% Overvalued

Profitability > metrics > ROE

-1.0376752275623757

Profitability > metrics > Net Margin

-20.149389579245696

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.007646469693593887

Risk > metrics > Interest Coverage

-21.359990489022746

Risk > final Score

-25

Risk > verdict

High

Liquidity > metrics > Current Ratio

0

Liquidity > metrics > Quick Ratio

0

Liquidity > final Score

10

Liquidity > verdict

Weak

Prev Valuations > 0

100

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

72

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

68

Prev Risks > 1

59

Prev Risks > 2

59

Prev Liquidities > 0

18

Prev Liquidities > 1

50

Prev Liquidities > 2

50

Updated At

2025-12-14T00:24:33.977Z